Ladiratuzumab
Product Specifications
CAS Number
1629760-28-6
Target
Others|||ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related|||Others
Purity
0.982
Bioactivity
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.LadiratuzumAb can be used for the prevention and treatment of breast cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1401272-01 0.5 mg (E-Coli)
Recombinant Mouse Receptor-type tyrosine-protein phosphatase T (Ptprt), partial
Ask
View Details 
MBS1401272-02 0.05 mg (Baculovirus)
Recombinant Mouse Receptor-type tyrosine-protein phosphatase T (Ptprt), partial
Ask
View Details MBS1401272-03 0.5 mg (Yeast)
Recombinant Mouse Receptor-type tyrosine-protein phosphatase T (Ptprt), partial
Ask
View Details MBS1401272-04 0.05 mg (Mammalian-Cell)
Recombinant Mouse Receptor-type tyrosine-protein phosphatase T (Ptprt), partial
Ask
View Details MBS1401272-05 1 mg (E-Coli)
Recombinant Mouse Receptor-type tyrosine-protein phosphatase T (Ptprt), partial
Ask
View Details MBS1401272-06 0.1 mg (Baculovirus)
Recombinant Mouse Receptor-type tyrosine-protein phosphatase T (Ptprt), partial
Ask
View Details